Considerations in selecting an inhaled anesthetic agent: Case studies

American Journal of Health-System Pharmacy

Volumn 61, Issue SUPPL. 4, 2004, Pages

  Golembiewski, Julie ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Age; Anesthetics; Desflurane; Drug administration routes; Drugs; Duration of action; Halothane; Isoflurane; Metabolism; Obesity; Pediatrics; Pharmacodynamics; Pharmacokinetics; Sevoflurane; Solubility; Surgery; Tissue levels; Toxicity; Weight

Indexed keywords

ADRENALIN; ALCOHOL; ALFENTANIL; ANALGESIC AGENT; ANESTHETIC AGENT; ATRACURIUM; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; CLONIDINE; DESFLURANE; DEXMEDETOMIDINE; ESMOLOL; FENTANYL; HALIDE; HALOTHANE; ISOFLURANE; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OPIATE; OPIATE AGONIST; PROPOFOL; RAPACURONIUM BROMIDE; ROCURONIUM; SALBUTAMOL; SEDATIVE AGENT; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG;

AGITATION; ARRHYTHMOGENESIS; ASTHMA; BRADYCARDIA; BREATH HOLDING; BRONCHODILATING ACTIVITY; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; COUGHING; DELIRIUM; DRUG ELIMINATION; DRUG METABOLISM; DRUG SOLUBILITY; ENDOTRACHEAL INTUBATION; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCAPNIA; HYPOTENSION; HYPOVENTILATION; HYPOXIA; KIDNEY FAILURE; LARYNX SPASM; LIVER TOXICITY; MUSCLE RELAXATION; MYOCARDIAL DISEASE; NEPHROTOXICITY; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; SIDE EFFECT;

EID: 5444224596     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.suppl_4.s10     Document Type: Conference Paper

References (41)

1. Stoelting RK, Miller RD. Anesthesia systems. In: Basics of Anesthesia, 4th ed. Stoelting RK, Miller RD, eds. New York: Churchill Livingstone; 2000:131-47.
2. Brimacombe J. The advantages of the LMA over the tracheal tube or face mask: a meta-analysis. Can J Anaesth. 1995; 42: 1017-23.
3. Fee JP, Thompson GH. Comparative tolerability profiles of the inhaled anaesthetics. Drug Saf. 1997; 16:157-70.
4. Park KW. Cardiovascular effects of inhalational anesthetics. Int Anesthesiol Clin. 2002; 40:1-14.
5. Weiskopf RB, Moore MA, Eger EI II et al. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology. 1994; 80:1035-45.
6. Muzi M, Ebert TJ, Hope WG et al. Site(s) mediating sympathetic activation with desflurane. Anesthesiology. 1996; 85:737-47.
7. Weiskopf RB, Eger EI II, Noorani M et al. Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans. Anesthesiology. 1994; 81:1350-5.
8. Suprane package insert. Deerfield, IL: Baxter Healthcare Corporation; 2001 Jan.
9. Tanaka S, Tsuchada H, Nakabayash K et al. The effects of sevoflurane, isoflurane, halothane, and enflurane on hemodynamic responses during inhaled induction of anesthesia via a mask in humans. Anesth Analg. 1996; 82:821-6.
10. Navarro R, Weiskopf RB, Moore MA et al. Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic responses to epinephrine. Anesthesiology. 1994; 80:545-9.
11. Piriou V, Chiari P, Lhuillier F et al. Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium. Br J Anaesth. 2002; 89:486-91.
12. Carson BA, Gamperi K, Slocum RE et al. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology. 1999; 87:1182-90.
13. Toller WG, Kersten JR, Pagel PS et al. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology. 1999; 91:1437-46.
14. Warltier DC, Al-wathiqui MH, Kampine JP et al. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology. 1988; 69: 552-65.
15. Meissner A, Weber TP, Van Aken H et al. Recovery from myocardial stunning is faster with desflurane compared with propofol in chronically instrumented dogs. Anesth Analg. 2000; 91:1333-8.
16. Dikmen Y, Eminoglu E, Salihoglu Z et al. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia. 2003; 58:745-8.
17. Stoelting RK, Miller RD. Effects of inhaled anesthetics on circulation and ventilation. In: Basics of Anesthesia, 4th ed. Stoelting RK, Miller RD, eds. New York: Churchill Livingstone; 2000:46-57.
18. Ultane package insert. North Chicago, IL: Abbott Laboratories; 2003 Aug.
19. Spracklin DK, Hankins DC, Fisher JM et al. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther. 1997; 281:400-11.
20. Reichle FM, Conzen PF. Halogenated inhalational anesthetics. Best Prat Res Clin Anaesthesiol. 2003; 17:29-46.
21. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology. 1995; 82:689-99.
22. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: Comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology. 1997; 86:1231-7.
23. Bailey JM. Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth Analg. 1997; 85:681-6.
24. Gelman S, Fowler KC, Smith LR. Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology. 1984; 61:726-30.
25. Eger EI II. Desflurane (Suprane): A compendium and reference. Nutley, NJ: Anaquest; 1993:1-119.
26. Hirshman CA, Bergman NA. Factors influencing intrapulmonary airway caliber during anesthesia. Br J Anaesth. 1990; 65:30-42.
27. Dikmen Y, Eminoglu E, Salihoglu Z et al. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia. 2003; 58:745-8.
28. Rooke G, Alec MD, Choi JH et al. The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology. 1997; 86: 1294-9.
29. Scalfaro P, Sly PD, Sims C et al. Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children. Anesth Analg. 2001; 93:898-902.
30. Gupta A, Stierer T, Zuckerman R et al. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg. 2004; 98:632-41.
31. Mahmoud NA, Rose DJ, Laurence AS. Desflurane or sevoflurane for gynaecological day-case anaesthesia with spontaneous respiration? Anaesthesia. 2001; 56:171-4.
32. Coloma M, Zhou T, White PF et al. Fast-tracking after outpatient laparoscopy: reasons for failure after propofol, sevoflurane, and desflurane anesthesia. Anesth Analg. 2001; 93:112-5.
33. Ogunriaike BO, Jones SB, Jones DB et al. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002; 95:1793-805.
34. Stoelting RK, Miller RD. Endocrine and nutritional disease. In: Basics of Anesthesia, 4th ed. Stoelting RK, Miller RD, eds. New York: Churchill Livingstone; 2000: 307-20.
35. Juvin P, Vadam C, Malek L et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective, randomized study. Anesth Analg. 2000; 91:714-9.
36. Sollazzi L, Perilli V, Modesti C et al. Volatile anesthesia in bariatric surgery. Obes Surg. 2001; 11:623-6.
37. Torri G, Casati A, Albertin A et al. Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients. J Clin Anesth. 2001; 13:565-70.
38. Torri G, Casati A, Comotti L et al. Washin and wash-out curves of sevoflurane and isoflurane in morbidly obese patients. Minerva Anestesiol. 2002; 68:523-7.
39. Morray JP, Geiduschek JM, Ramamoorthy C et al. Anesthesia-related cardiac arrest in children: initial findings of the Pediatric Perioperative Cardiac Arrest (POCA) Registry. Anesthesiology. 2000; 93:6-14.
40. Lulka PJ, Bressem M, Tryba M. Clonidine prevents sevoflurane-induced agitation in children. Anesth Analg. 2001; 93:335-8.
41. Ibacache ME, Munoz HR, Brandes V et al. Single-dose dexmedetomidine reduces agitation after sevoflurane in children. Anesth Analg. 2004; 98:60-3.